Illumina Unveils Strategic Roadmap for Market Expansion Business Wire (press release) In emerging markets, Illumina will launch a human leukocyte antigen (HLA) typing product in mid-2014 for laboratories seeking next-generation sequencing on the MiSeq® platform that will be faster, less expensive, and more accurate than current ... |
